{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:18:32Z","timestamp":1791839912017,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Toxic epidermal necrolysis (TEN) patients require multi-directional and multi-disciplinary treatment. In most cases, they are hospitalised at intensive care units and require multi-directional, burn-complication preventive care. Choosing the most appropriate treatment option might be troublesome even when predicting scores are used. SCORTEN is the most renowned prognostic score for TEN patients, however, there are some data indicating that the accuracy of this test may be limited. The credibility of not just the predicted mortality risk, but also componential laboratory results and clinical features subject to debate. The aim of this study was to evaluate the efficacy and credibility of SCORTEN in clinical practice, on proprietary material.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective analysis of 35 patients with diagnosed in histopathology TEN was performed. The inclusion criteria were as follows: day of submission before 5th day from the onset of the symptoms, full protocol of plasmaphereses and IVIGs according to our scheme. Our protocol includes cycle of plasmapheresis with frozen fresh plasma twice daily for the first 2 days following admission, and once daily for the subsequent 5 to 7 days. IVIGs were administered after the first two sessions of plasmapheresis, for 4 to 7 days. The dosage was calculated according to body weight, at 0.4 to 0.5\u00a0g\/kg per dose.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The sensitivity of SCORTEN for the analysed cohort was 100%, with a specificity of 24%. The estimated death was 41,9%, while the actual death rates were 12,5%. Our protocol improved the survival, OR\u2009=\u200926,57, RR\u2009=\u20096,34, p\u2009=\u20090,022. Decrease in mortality was caused by a combined treatment protocol we use- plasmaphereses with IVIGs. No independent risk factor was significant in death evaluation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our data suggest that the scoring system for predicting death among TEN patients are reliable when they are high. New prognostic factors should be found to improve the evaluation of patients with low SCORTEN.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-022-02013-2","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T12:03:57Z","timestamp":1666181037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Accuracy of SCORTEN in predicting mortality in toxic epidermal necrolysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Jerzy","family":"Stru\u017cyna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3360-716X","authenticated-orcid":false,"given":"Agnieszka","family":"Surowiecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Korzeniowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Korulczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Drozd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldona","family":"Stachura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"2013_CR1","doi-asserted-by":"crossref","unstructured":"Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017 Oct 28;390(10106):1996\u20132011. doi: 10.1016\/S0140-6736(16)30378-6. Epub 2017 May 2. Erratum in: Lancet. 2017 Oct 28;390(10106):1948. PMID: 28476287.","DOI":"10.1016\/S0140-6736(16)30378-6"},{"key":"2013_CR2","doi-asserted-by":"crossref","unstructured":"Woolum JAPharmD, Bailey AM, PharmD BCPS, Baum RAPharmD, Metts EL. PharmD, BCPS A Review of the Management of Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis, Advanced Emergency Nursing Journal: January\/March 2019 - Volume\u00a041 - Issue 1 - p\u00a056\u201364.","DOI":"10.1097\/TME.0000000000000225"},{"key":"2013_CR3","doi-asserted-by":"publisher","unstructured":"Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clin Rev Allergy Immunol. 2018 Feb;54(1):147\u2013176. doi: https:\/\/doi.org\/10.1007\/s12016-017-8654-z. PMID: 29188475.","DOI":"10.1007\/s12016-017-8654-z"},{"issue":"9","key":"2013_CR4","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/jdv.16339","volume":"34","author":"EC Kuijper","year":"2020","unstructured":"Kuijper EC, French LE, Tensen CP, Vermeer MH, Bouwes Bavinck JN. Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN). J Eur Acad Dermatol Venereol. 2020;34(9):1957\u201371. doi:https:\/\/doi.org\/10.1111\/jdv.16339.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2013_CR5","doi-asserted-by":"publisher","unstructured":"Charlton OA, Harris V, Phan K, Mewton E, Jackson C, Cooper A. Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review. Adv Wound Care (New Rochelle). 2020 Jul;9(7):426\u2013439. doi: https:\/\/doi.org\/10.1089\/wound.2019.0977. Epub 2020 Jan 9. PMID: 32520664; PMCID: PMC7307670.","DOI":"10.1089\/wound.2019.0977"},{"key":"2013_CR6","doi-asserted-by":"publisher","unstructured":"Schulz JT, Sheridan RL, Ryan CM, MacKool B, Tompkins RG. A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil. 2000 May-Jun;21(3):199\u2013204. doi: https:\/\/doi.org\/10.1097\/00004630-200021030-00004. PMID: 10850900.","DOI":"10.1097\/00004630-200021030-00004"},{"issue":"1","key":"2013_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/jdv.16685","volume":"35","author":"I Torres-Navarro","year":"2021","unstructured":"Torres-Navarro I, Briz-Red\u00f3n \u00c1, Botella-Estrada R. Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):159\u201371. doi:https:\/\/doi.org\/10.1111\/jdv.16685. Epub 2020 Jul 23. PMID: 32946187.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"2013_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.burns.2009.06.213","volume":"36","author":"M Lissia","year":"2010","unstructured":"Lissia M, Mulas P, Bulla A, Rubino C. Toxic epidermal necrolysis (Lyell\u2019s disease). Burns. 2010;36(2):152\u201363. \u201c,\u201d, .","journal-title":"Burns"},{"key":"2013_CR9","doi-asserted-by":"publisher","unstructured":"Hsu DY, Brieva J, Silverberg NB, Silverberg JI. (2016). Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults. Journal of Investigative Dermatology, 136(7), 1387\u20131397.doi:https:\/\/doi.org\/10.1016\/j.jid.2016.03.023.","DOI":"10.1016\/j.jid.2016.03.023"},{"issue":"6","key":"2013_CR10","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s12325-017-0530-y","volume":"34","author":"JA Schneider","year":"2017","unstructured":"Schneider JA, Cohen PR. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Adv Ther. 2017;34(6):1235\u201344. doi:https:\/\/doi.org\/10.1007\/s12325-017-0530-y.","journal-title":"Adv Ther"},{"key":"2013_CR11","doi-asserted-by":"publisher","unstructured":"Noe MH, Rosenbach M, Hubbard RA, Mostaghimi A, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Hughey LC, Kaffenberger BH, Kroshinsky D, Kwong BY, Miller DD, Musiek A, Ortega-Loayza AG, Sharon VR, Shinkai K, Summers EM, Wanat KA, Wetter DA, Worswick S, Margolis DJ, Gelfand JM, Micheletti RG. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis-ABCD-10. JAMA Dermatol. 2019 Apr 1;155(4):448\u2013454. doi: https:\/\/doi.org\/10.1001\/jamadermatol.2018.5605. Erratum in: JAMA Dermatol. 2019 Jul 31;: Erratum in: JAMA Dermatol. 2019 Sep 1;155(9):1090. Kroshinsky, Daniel [corrected to Kroshinsky, Daniela]. PMID: 30840032; PMCID: PMC6459085.","DOI":"10.1001\/jamadermatol.2018.5605"},{"issue":"6","key":"2013_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1055\/s-2001-18868","volume":"27","author":"T van der Poll","year":"2001","unstructured":"van der Poll T, de Jonge E, Levi M. Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27(6):639\u201351.","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"2013_CR13","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.jaad.2020.08.065","volume":"84","author":"CB Chen","year":"2021","unstructured":"Chen CB, Hsu TH, Chung-Yee Hui R, Lu CW, Chen WT, Chiang PH, Wang CW, Chuang SS, Yang JY, Yang SY, Chang SY, Hsiao YC, Kao KC, Hu HC, Wu TS, Hsu CW, Hui-Kang Ma D, Chen SY, Tian YC, Cheng CY, Chen CH, Chi MH, Wu MY, Liu RF, Wang CH, Chang YC, Lin JY, Ho HC, Lin Y-W, Chang Y, Lin CJ, Ku YJ, Hung CL, Chung SI. WH; Taiwan Severe Cutaneous Adverse Reaction Consortium. Disseminated intravascular coagulation in Stevens-Johnson syndrome and toxic epidermal necrolysis. J Am Acad Dermatol. 2021 Jun;84(6):1782\u201391. doi:https:\/\/doi.org\/10.1016\/j.jaad.2020.08.065. Epub 2020 Aug 20. PMID: 32828861.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2013_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.burns.2006.07.004","volume":"33","author":"Y Tanaka","year":"2007","unstructured":"Tanaka Y, Shimizu M, Hirabayashi H. Acute physiology, age, and chronic health evaluation (APACHE) III score is an alternative efficient predictor of mortality in burn patients. Burns. 2007 May;33(3):316\u201320. doi:https:\/\/doi.org\/10.1016\/j.burns.2006.07.004. Epub 2006 Dec 13. PMID: 17169494.","journal-title":"Burns"},{"issue":"7","key":"2013_CR15","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.burns.2015.06.009","volume":"41","author":"JS Heng","year":"2015","unstructured":"Heng JS, Clancy O, Atkins J, Leon-Villapalos J, Williams AJ, Keays R, Hayes M, Takata M, Jones I, Vizcaychipi MP. Revised Baux Score and updated Charlson comorbidity index are independently associated with mortality in burns intensive care patients. Burns. 2015 Nov;41(7):1420\u20137. doi: 10.1016\/j.burns.2015.06.009. Epub 2015 Jul 14. PMID: 26187055.","journal-title":"Burns"},{"issue":"2","key":"2013_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.burns.2019.03.006","volume":"46","author":"A Prasad","year":"2020","unstructured":"Prasad A, Thode HC Jr, Singer AJ. Predictive value of quick SOFA and revised Baux scores in burn patients. Burns. 2020 Mar;46(2):347\u201351. doi:https:\/\/doi.org\/10.1016\/j.burns.2019.03.006. Epub 2019 Dec 16. PMID: 31859098.","journal-title":"Burns"},{"key":"2013_CR17","doi-asserted-by":"publisher","first-page":"6928363","DOI":"10.1155\/2017\/6928363","volume":"2017","author":"M Orime","year":"2017","unstructured":"Orime M. Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions. J Immunol Res. 2017;2017:6928363. doi:https:\/\/doi.org\/10.1155\/2017\/6928363.","journal-title":"J Immunol Res"},{"issue":"1","key":"2013_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1):92\u20136.","journal-title":"Arch Dermatol"},{"key":"2013_CR19","doi-asserted-by":"publisher","unstructured":"Torres-Navarro I, Briz-Red\u00f3n \u00c1, Botella-Casas G, Sahuquillo-Torralba A, Calle-Andrino A, de Unamuno-Bustos B, Piqueras-Garc\u00eda J, Roca Gin\u00e9s J, Magdaleno Tapial J, Alegre de Miquel V, Botella-Estrada R. Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome\/toxic epidermal necrolysis. J Dermatol. 2020 Oct;47(10):1182\u20131186. doi: https:\/\/doi.org\/10.1111\/1346-8138.15490. Epub 2020 Aug 27. PMID: 32856355.","DOI":"10.1111\/1346-8138.15490"},{"key":"2013_CR20","doi-asserted-by":"publisher","unstructured":"Koh HK, Fook-Chong S, Lee HY. Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis. JAMA Dermatol. 2020 Dec 1;156(12):1294\u20131299. doi: https:\/\/doi.org\/10.1001\/jamadermatol.2020.3654. PMID: 33084873; PMCID: PMC7578915.","DOI":"10.1001\/jamadermatol.2020.3654"},{"key":"2013_CR21","doi-asserted-by":"publisher","unstructured":"Imahara SD, Holmes JH 4th, Heimbach DM, Engrav LE, Honari S, Klein MB, Gibran NS. SCORTEN overestimates mortality in the setting of a standardized treatment protocol. J Burn Care Res. 2006 May-Jun;27(3):270-5. doi: https:\/\/doi.org\/10.1097\/01.BCR.0000216532.71360.9B. PMID: 16679892.","DOI":"10.1097\/01.BCR.0000216532.71360.9B"},{"key":"2013_CR22","doi-asserted-by":"publisher","unstructured":"Zavala S, O\u2019Mahony M, Joyce C, Baldea AJ. How Does SCORTEN, Score?. J Burn Care Res. 2018 Jun 13;39(4):555\u2013561. doi: https:\/\/doi.org\/10.1093\/jbcr\/irx016. PMID: 29789855.","DOI":"10.1093\/jbcr\/irx016"},{"issue":"9","key":"2013_CR23","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","volume":"123","author":"J Revuz","year":"1987","unstructured":"Revuz J, Penso D, Roujeau J, et al. Toxic Epidermal Necrolysis: Clinical Findings and Prognosis Factors in 87 Patients. Arch Dermatol. 1987;123(9):1160\u20135. doi:https:\/\/doi.org\/10.1001\/archderm.1987.01660330071012.","journal-title":"Arch Dermatol"},{"issue":"2","key":"2013_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.alit.2020.11.004","volume":"70","author":"T Watanabe","year":"2021","unstructured":"Watanabe T, Go H, Saigusa Y, Takamura N, Watanabe Y, Yamane Y, Totsuka M, Ishikawa H, Nakamura K, Matsukura S, Kambara T, Takaki S, Yamaguchi Y, Aihara M. Mortality and risk factors on admission in toxic epidermal necrolysis: A cohort study of 59 patients. Allergology Int. 2021;70(2):229\u201334.","journal-title":"Allergology Int"},{"key":"2013_CR25","doi-asserted-by":"publisher","unstructured":"Thakur V, Vinay K, Kumar S, Choudhary R, Kumar A, Parsad D, Kumaran MS. Factors Predicting the Outcome of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 5-Year Retrospective Study. Indian Dermatol Online J. 2021 Mar 2;12(2):258\u2013265. doi: https:\/\/doi.org\/10.4103\/idoj.IDOJ_437_20. PMID: 33959522; PMCID: PMC8088174.","DOI":"10.4103\/idoj.IDOJ_437_20"},{"key":"2013_CR26","doi-asserted-by":"publisher","unstructured":"Vaishampayan SS, Das AL, Verma R. SCORTEN: does it need modification? Indian J Dermatol Venereol Leprol. 2008 Jan-Feb;74(1):35 \u2013 7. doi: https:\/\/doi.org\/10.4103\/0378-6323.38405. PMID: 18187821.","DOI":"10.4103\/0378-6323.38405"},{"key":"2013_CR27","doi-asserted-by":"publisher","unstructured":"Wernly B, Lichtenauer M, Vellinga NAR, Boerma EC, Ince C, Kelm M, Jung C. Blood urea nitrogen (BUN) independently predicts mortality in critically ill patients admitted to ICU: A multicenter study. Clin Hemorheol Microcirc. 2018;69(1\u20132):123\u2013131. doi: https:\/\/doi.org\/10.3233\/CH-189111. PMID: 29758935.","DOI":"10.3233\/CH-189111"},{"issue":"1","key":"2013_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-020-0145-5","volume":"6","author":"MG Jeschke","year":"2020","unstructured":"Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nat Rev Dis Primers. 2020;6(1):11. doi:https:\/\/doi.org\/10.1038\/s41572-020-0145-5. Published 2020 Feb 13.","journal-title":"Nat Rev Dis Primers"},{"key":"2013_CR29","unstructured":"Bellomo R, Ronco C, Kellum J, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative(ADQI) Group. Critical Care. 2004;8:R204\u201312."},{"issue":"4","key":"2013_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/BCR.0b013e31825aea8d","volume":"33","author":"KK Chung","year":"2012","unstructured":"Chung KK, Steward IJ, Gisler C, et al. The acute kidney injury network(AKIN) criteria applied in burns. J Burn Care Res. 2012;33(4):483\u201390.","journal-title":"J Burn Care Res"},{"key":"2013_CR31","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mechta","year":"2007","unstructured":"Mechta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of initiative to improve outcome in acute kidney injury. Crit Care. 2007;11:R31.","journal-title":"Crit Care"},{"key":"2013_CR32","doi-asserted-by":"publisher","unstructured":"Szczeklik W, Nowak I, Seczynska B, Sega A, Krolikowski W, Musial J. Beneficial therapeutic effect of plasmapheresis after unsuccessful treatment with corticosteroids in two patients with severe toxic epidermal necrolysis. Ther Apher Dial. 2010 Jun;14(3):354-7. doi: https:\/\/doi.org\/10.1111\/j.1744-9987.2009.00800.x. PMID: 20609191.","DOI":"10.1111\/j.1744-9987.2009.00800.x"},{"key":"2013_CR33","doi-asserted-by":"crossref","unstructured":"Al-Kindi SG, Sarode A, Zullo M, Rajagopalan S, Rahman M, Hostetter T, Dobre M. Serum Bicarbonate Concentration and Cause-Specific Mortality: The National Health and Nutrition Examination Survey 1999\u20132010. Mayo Clin Proc. 2020 Jan;95(1):113\u2013123. doi: 10.1016\/j.mayocp.2019.05.036. Epub 2019 Dec 4. PMID: 31812253.","DOI":"10.1016\/j.mayocp.2019.05.036"},{"key":"2013_CR34","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1038\/s41598-019-38892-1","volume":"9","author":"SY Lim","year":"2019","unstructured":"Lim SY, Park Y, Chin HJ, et al. Short-term and long-term effects of low serum bicarbonate level at admission in hospitalised patients. Sci Rep. 2019;9<bvertical-align:super;>,<\/bvertical-align:super;><bvertical-align:super;>:<\/bvertical-align:super;>2798. https:\/\/doi.org\/10.1038\/s41598-019-38892-1.","journal-title":"Sci Rep"},{"key":"2013_CR35","doi-asserted-by":"publisher","unstructured":"Yeong EK, Lee CH, Hu FC, M Z W. Serum bicarbonate as a marker to predict mortality in toxic epidermal necrolysis. J Intensive Care Med. 2011 Jul-Aug;26(4):250-4. doi: https:\/\/doi.org\/10.1177\/0885066610390466. PMID: 21887862.","DOI":"10.1177\/0885066610390466"},{"issue":"5","key":"2013_CR36","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/bjd.14052","volume":"173","author":"J Wu","year":"2015","unstructured":"Wu J, Lee YY, Su SC, Wu TS, Kao KC, Huang CC, Chang WC, Yang CH, Chung WH. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies. Br J Dermatol. 2015 Nov;173(5):1224\u201331. doi:https:\/\/doi.org\/10.1111\/bjd.14052. Epub 2015 Oct 19. PMID: 26218033.","journal-title":"Br J Dermatol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-02013-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-022-02013-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-02013-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T12:12:12Z","timestamp":1666181532000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-022-02013-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2013"],"URL":"https:\/\/doi.org\/10.1186\/s12911-022-02013-2","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"assertion":[{"value":"16 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"it was a retrospective study, done according to the Declaration of Helsinki were respected. The study protocol and individuals\u2019 participation were approved by the Ethics Committee of the Independent Public District Hospital in \u0141\u0119czna. The need for informed consent was waived by the ethics committee\/Institutional Review Board of Ethics Committee of the Independent Public District Hospital in \u0141\u0119czna, because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not aplicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}}],"article-number":"273"}}